Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1993 May;109(1):251–258. doi: 10.1111/j.1476-5381.1993.tb13561.x

Effects of the kappa-opioid agonist U50,488 on parturition in rats.

A J Douglas 1, G Clarke 1, S J MacMillan 1, P M Bull 1, I Neumann 1, S A Way 1, D M Wright 1, B G McGrory 1, J A Russell 1
PMCID: PMC2175571  PMID: 8388299

Abstract

1. The effects of the kappa-opioid agonist U50,488 on parturition were studied in the rat. 2. Given directly after the birth of the second pup U50,488 (5 mg or 10 mg kg-1, i.p.) delayed the birth of the subsequent 4 pups by ca. 100 min, acting like morphine (10 mg kg-1, i.p.). In controls given the vehicle i.p., the birth of the 4 pups after treatment took 45.4 +/- 4.6 min. The effects of U50,488 could be prevented by simultaneous naloxone injection (10 mg kg-1). Injection of either U50,488 or morphine at 1 mg kg-1, i.v. also significantly delayed parturition. The effects of U50,488 but not of morphine were fully prevented by preinjection with nor-binaltorphimine (0.5 mg kg-1, i.v.) showing selective kappa-opioid receptor-mediated inhibition by U50,488 of established parturition. 3. In rats with an indwelling jugular venous cannula, i.v. injection of U50,488 (5 mg kg-1) after the birth of the second pup slowed parturition in a similar way to i.p. injection and significantly reduced blood plasma oxytocin concentration measured by radioimmunoassay compared with vehicle-injected controls. 4. Bolus i.v. injections of oxytocin (4 mu once per 5 min) significantly reduced the delay in parturition caused by i.v. U50,488, but continuous i.v. infusion of oxytocin (4 mu 5 min-1) was less effective. 5. Since i.v. oxytocin did not immediately reverse the effects of U50,488 on parturition, direct effects of U50,488 on isometric uterine contractions in vitro were sought.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
251

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bicknell R. J., Leng G., Russell J. A., Dyer R. G., Mansfield S., Zhao B. G. Hypothalamic opioid mechanisms controlling oxytocin neurones during parturition. Brain Res Bull. 1988 Jun;20(6):743–749. doi: 10.1016/0361-9230(88)90086-x. [DOI] [PubMed] [Google Scholar]
  2. Clark J. A., Liu L., Price M., Hersh B., Edelson M., Pasternak G. W. Kappa opiate receptor multiplicity: evidence for two U50,488-sensitive kappa 1 subtypes and a novel kappa 3 subtype. J Pharmacol Exp Ther. 1989 Nov;251(2):461–468. [PubMed] [Google Scholar]
  3. Clark J. A., Pasternak G. W. U50,488: a kappa-selective agent with poor affinity for mu1 opiate binding sites. Neuropharmacology. 1988 Mar;27(3):331–332. doi: 10.1016/0028-3908(88)90052-4. [DOI] [PubMed] [Google Scholar]
  4. Hayes A. G., Birch P. P., Cavicchini E. Evidence that the kappa agonist U50488H has non-opioid actions. J Pharm Pharmacol. 1988 Oct;40(10):718–720. doi: 10.1111/j.2042-7158.1988.tb07002.x. [DOI] [PubMed] [Google Scholar]
  5. Herkenham M., Rice K. C., Jacobson A. E., Rothman R. B. Opiate receptors in rat pituitary are confined to the neural lobe and are exclusively kappa. Brain Res. 1986 Sep 24;382(2):365–371. doi: 10.1016/0006-8993(86)91346-6. [DOI] [PubMed] [Google Scholar]
  6. Higuchi T., Tadokoro Y., Honda K., Negoro H. Detailed analysis of blood oxytocin levels during suckling and parturition in the rat. J Endocrinol. 1986 Aug;110(2):251–256. doi: 10.1677/joe.0.1100251. [DOI] [PubMed] [Google Scholar]
  7. Kosterlitz H. W. The Wellcome Foundation lecture, 1982. Opioid peptides and their receptors. Proc R Soc Lond B Biol Sci. 1985 Jul 22;225(1238):27–40. doi: 10.1098/rspb.1985.0048. [DOI] [PubMed] [Google Scholar]
  8. Lefebvre D. L., Giaid A., Bennett H., Larivière R., Zingg H. H. Oxytocin gene expression in rat uterus. Science. 1992 Jun 12;256(5063):1553–1555. doi: 10.1126/science.1598587. [DOI] [PubMed] [Google Scholar]
  9. Leng G., Mansfield S., Bicknell R. J., Blackburn R. E., Brown D., Chapman C., Dyer R. G., Hollingsworth S., Shibuki K., Yates J. O. Endogenous opioid actions and effects of environmental disturbance on parturition and oxytocin secretion in rats. J Reprod Fertil. 1988 Sep;84(1):345–356. doi: 10.1530/jrf.0.0840345. [DOI] [PubMed] [Google Scholar]
  10. Mann P. E., Kinsley C. H., Bridges R. S. Opioid receptor subtype involvement in maternal behavior in lactating rats. Neuroendocrinology. 1991 May;53(5):487–492. doi: 10.1159/000125762. [DOI] [PubMed] [Google Scholar]
  11. Mansour A., Khachaturian H., Lewis M. E., Akil H., Watson S. J. Anatomy of CNS opioid receptors. Trends Neurosci. 1988 Jul;11(7):308–314. doi: 10.1016/0166-2236(88)90093-8. [DOI] [PubMed] [Google Scholar]
  12. McFadzean I., Lacey M. G., Hill R. G., Henderson G. Kappa opioid receptor activation depresses excitatory synaptic input to rat locus coeruleus neurons in vitro. Neuroscience. 1987 Jan;20(1):231–239. doi: 10.1016/0306-4522(87)90015-7. [DOI] [PubMed] [Google Scholar]
  13. Neumann I., Russell J. A., Wolff B., Landgraf R. Naloxone increases the release of oxytocin, but not vasopressin, within limbic brain areas of conscious parturient rats: a push-pull perfusion study. Neuroendocrinology. 1991 Dec;54(6):545–551. doi: 10.1159/000125958. [DOI] [PubMed] [Google Scholar]
  14. Portoghese P. S., Nagase H., Lipkowski A. W., Larson D. L., Takemori A. E. Binaltorphimine-related bivalent ligands and their kappa opioid receptor antagonist selectivity. J Med Chem. 1988 Apr;31(4):836–841. doi: 10.1021/jm00399a026. [DOI] [PubMed] [Google Scholar]
  15. Pumford K. M., Leng G., Russell J. A. Morphine actions on supraoptic oxytocin neurones in anaesthetized rats: tolerance after i.c.v. morphine infusion. J Physiol. 1991;440:437–454. doi: 10.1113/jphysiol.1991.sp018717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Russell J. A., Gosden R. G., Humphreys E. M., Cutting R., Fitzsimons N., Johnston V., Liddle S., Scott S., Stirland J. A. Interruption of parturition in rats by morphine: a result of inhibition of oxytocin secretion. J Endocrinol. 1989 Jun;121(3):521–536. doi: 10.1677/joe.0.1210521. [DOI] [PubMed] [Google Scholar]
  17. Russell J. A., Leng G., Coombes J. E., Crockett S. A., Douglas A. J., Murray I., Way S. Pethidine (meperidine) inhibition of oxytocin secretion and action in parturient rats. Am J Physiol. 1991 Aug;261(2 Pt 2):R358–R368. doi: 10.1152/ajpregu.1991.261.2.R358. [DOI] [PubMed] [Google Scholar]
  18. Summerlee A. J. Extracellular recordings from oxytocin neurones during the expulsive phase of birth in unanaesthetized rats. J Physiol. 1981 Dec;321:1–9. doi: 10.1113/jphysiol.1981.sp013967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Sumner B. E., Douglas A. J., Russell J. A. Pregnancy alters the density of opioid binding sites in the supraoptic nucleus and posterior pituitary gland of rats. Neurosci Lett. 1992 Mar 30;137(2):216–220. doi: 10.1016/0304-3940(92)90407-x. [DOI] [PubMed] [Google Scholar]
  20. Wakerley J. B., Noble R., Clarke G. Effects of morphine and D-Ala, D-Leu enkephalin on the electrical activity of supraoptic neurosecretory cells in vitro. Neuroscience. 1983 Sep;10(1):73–81. doi: 10.1016/0306-4522(83)90081-7. [DOI] [PubMed] [Google Scholar]
  21. Wright D. M. Evidence for a spinal site at which opioids may act to inhibit the milk-ejection reflex. J Endocrinol. 1985 Sep;106(3):401–407. doi: 10.1677/joe.0.1060401. [DOI] [PubMed] [Google Scholar]
  22. Zhao B. G., Chapman C., Bicknell R. J. Opioid-noradrenergic interactions in the neurohypophysis. I. Differential opioid receptor regulation of oxytocin, vasopressin, and noradrenaline release. Neuroendocrinology. 1988 Jul;48(1):16–24. doi: 10.1159/000124984. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES